After Achieving 100% Cancer Remission Rates In Preclinical Studies, Starpax Magnetodrones Head For Human Trials
–News Direct– By Rachael Green, Benzinga Starpax Biopharma is preparing to start clinical trials this year with its patented Starpax cancer treatment platform across six …